Diabetes Landscape: Market, Technology & Intellectual Property

  • Overview

    A major 2-volume joint research report from TechInsights and Espicom.

    This unprecedented combination of market, technology and intellectual property information will provide a detailed look at the diabetes treatment and monitoring device sector . It is a must-read for those companies looking to understand how intellectual property trends in the diabetes device sector relate to market opportunities.

    Highlights: (Download executive summary report here)

    • Know the market share of leading companies and market forecasts by diabetes device technology sector and geography
    • Access up to date company analyses for leading diabetes device manufacturers
    • Understand the emerging trends and their commercialization status
    • Learn how patent activity is trending across diabetes device technology sectors
    • Access patent and product portfolio assessments for 12 leading diabetes device manufacturers
    • Identify strong patents in each technology sector
    • Analysis of sample patents in each technology sector – including top forward citing companies

    Who should read this report:

    • Intellectual Property Professionals
    • Technology Licensing Specialists
    • Product Development Executives
    • Product and Marketing Managers
    • CTOs and Technical Managers
    • Researchers working in the diabetes sector
    • Suppliers to the diabetes device industry

    Interested in the diabetes landscape report? Purchase it here.

    Market Analysis

    • Over 100 companies included.
    • Market forecasts by device technology and geography.
    • Key company analyses include: products, recent key events, current alliances, litigation, and financial performance.
    • Description of products available and under-development in each technology sub-category.

    Companies profiled in detail:

    • Abbott
    • Arkray
    • Bayer
    • BD
    • DexCom
    • Insulet
    • J&J
    • Medtronic
    • Nipro Diagnostics
    • Roche
    • Sanofi
    • Terumo
    • Ypsomed

    This volume is produced by Espicom Business Intelligence.

    About Espicom:
    Espicom is a highly-regarded and established independent provider of business intelligence services for the global medtech industries. Based in the UK and with over 30 years of continuous research and editorial experience in the global health industry, Espicom is one of the longest established, independent business intelligence providers operating today. Espicom produces original analysis, news and forecasts using its skilled and experienced team of full-time in-house analysts, researchers and editorial experts. Over 50,000 users in more than 50 countries worldwide rely on Espicom’s essential market data.

    Interested in the diabetes landscape report? Purchase it here.

    Technology & IP Analysis

    A forensic investigation of 5,900 patents in the diabetes device area has been distilled to provide a detailed assessment of who holds key technology patents worldwide.

    This volume provides an in-depth analysis of the technologies and IP associated with diabetes devices, including:

    • Diabetes Monitoring
    • Blood glucose meters and test strips
    • Continuous glucose monitoring
    • Non-invasive and emerging technologies
    • Diabetes Treatment
      • Insulin delivery (including pens and insulin pumps)
      • Open loop continuous glucose monitoring/pumps
      • Closed loop artificial pancreas technology
      • Software & Algorithms

    There are a significant number (over 500) of patent assignees. This reportprovides detailed analysis of:

    • Overall diabetes patent portfolio (including Priority Year, Patent Totals by Technology, Top Twenty Assignees, IP and USP Classifications)
    • Diabetes patents by technology subcategory (including Priority Date, Top Twenty Assignees, and Analysis of Sample Patents)
    • Diabetes patents by key company (including Priority Date, Patent Distribution by Technology, and Patent Source Jurisdiction)

    The diabetes device patent portfolio and product status of the following companies is covered in great detail:

    • Johnson & Johnson (Animas and Lifescan)
    • Abbott
    • Roche
    • Medtronic
    • Becton, Dickinson and Co (BD)
    • Dexcom
    • Novo Nordisk
    • Bayer
    • Insulet Corporation
    • Nipro Corporation
    • Arkray Inc
    • Sanofi (formerly Sanofi-Aventis)

    Interested in the diabetes landscape report? Purchase it here.

    ;

    Associated Teardown Reports

    Baseline Teardown Report on the LifeScan OneTouch UltraSmart Blood Glucose Monitoring System
    Baseline Teardown Report on the Roche ACCU-CHEK Mobile Blood Glucose Monitor
    Baseline Teardown Report on the Bionime Rightest GM550 Blood Glucose Monitor
    Baseline Teardown Report on the Nipro Diagnostics TRUE2Go Blood Glucose Monitor
    Baseline Teardown Report on the Medisana Glucodock Blood Glucose Monitor
    Baseline Teardown Report on the Insulet OmniPod
    Level 3 Teardown Report on the Dexcom Seven Plus Continuous Glucose Monitoring System
    Baseline Teardown Report on the Abbott FreeStyle Blood Glucose Monitor
    Baseline Teardown Report on the SinoCare SXT-1 Blood Glucose Monitor
    Baseline Teardown Report on the Bayer Contour USB Blood Glucose Monitoring System

    Complimentary Teardown Presentation: Animas OneTouch Ping Glucose Management System

    Interested in the diabetes landscape report? Purchase it here.

  • Resources

    Diabetes Landscape - Side Pic

    A Joint Research Report from Espicom and TechInsights

    Espicom - Logo     Espicom - Logo